Published in Acta Biotheor on September 01, 1992
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet (1996) 3.15
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41
Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.85
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71
Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut (1985) 1.60
Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab (2001) 1.58
Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood (1998) 1.56
Anal lesions: any significant prognosis in Crohn's disease? Eur J Gastroenterol Hepatol (1997) 1.49
Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum (2001) 1.44
Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood (1995) 1.39
Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution? Gut (1997) 1.38
A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol (1999) 1.27
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol (2001) 1.19
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol (2011) 1.09
Comparison of weight- and height-based indices for assessing the risk of death in severely malnourished children. Am J Epidemiol (1996) 1.03
A model to standardise mortality of severely malnourished children using nutritional status on admission to therapeutic feeding centres. Eur J Clin Nutr (1997) 1.01
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00
Effects of cholecystokinin and metoclopramide on jejunal movements of water and electrolytes and on transit time of luminal fluid in man. Eur J Clin Invest (1972) 0.96
Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol (1986) 0.88
A convenient source of CFU-s inhibitors: the fetal calf liver. Cell Tissue Kinet (1984) 0.88
Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol (2001) 0.88
Protection of mice against lethal doses of 1 beta-D-arabinofuranosylcytosine by pluripotent stem cell inhibitors. Cancer Res (1982) 0.86
[Factors related to 30th day mortality in upper digestive tract hemorrhage in cirrhotic patients (author's transl)]. Gastroenterol Clin Biol (1980) 0.84
Effects of synthetic human gastrin I on movements on water, electrolytes, and glucose across the human small intestine. Gastroenterology (1976) 0.84
Further studies on prostaglandin E1-induced jejunal secretion of water and electrolytes in man, with special reference to the influence of ethacrynic acid, furosemide, and aspirin. Gastroenterology (1976) 0.84
Down modulation of TNF-alpha mRNA placental expression by AZT used for the prevention of HIV-1 mother-to-child transmission. Placenta (2005) 0.83
Gastrin cell distribution in normal human stomachs and in patients with Zollinger-Ellison syndrome. Gastroenterology (1978) 0.83
Incubation time for AIDS from French transfusion-associated cases. Nature (1989) 0.83
Effect of feeding yogurt versus milk in children with persistent diarrhea. J Pediatr Gastroenterol Nutr (1990) 0.83
Global and partial agreement among several observers. Stat Med (1998) 0.82
[Effect of prostaglandin E 1 on transit time and net and unidirectional movements of water and electrolytes in the human jejunum]. Biol Gastroenterol (Paris) (1972) 0.82
Adult patients presenting with pancytopenia: a reappraisal of underlying pathology and diagnostic procedures in 213 cases. Hematol Pathol (1989) 0.82
Normal human granulopoiesis revisited. II. Bone marrow data. Biomed Pharmacother (1985) 0.81
Upper digestive tract hemorrhage in cirrhotic patients. Contribution of multidimensional analysis to the study of variables related to the cause of the hemorrhage. Dig Dis Sci (1981) 0.81
Effect of pentagastrin upon movements of water, electrolytes and glucose across the human jejunum and ileum. Digestion (1973) 0.80
Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia. Blood (1986) 0.80
The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors. Stem Cells (1993) 0.79
Gestational age determination and prevention of HIV perinatal transmission. Int J Gynaecol Obstet (2005) 0.79
Cell cycle models and mother-daughter correlation. J Theor Biol (1988) 0.79
Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther (2002) 0.78
Mathematical analysis of bone marrow erythropoiesis: application to C3H mouse data. Blood Cells (1980) 0.78
Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci (1995) 0.78
Modifications of hemato-biological parameters in pregnant women in a migrating population in northern Cameroon: prevalence of anemia, iron and folates deficiencies. Int J Vitam Nutr Res (1987) 0.77
[Intestinal absorption of vitamin D, linoleic acid and cholesterol from micellar solutions: study in normal humans by the "in situ" perfusion method]. Biol Gastroenterol (Paris) (1976) 0.77
Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp Hematol (1990) 0.77
Risk factors for fatal diarrhoea among dehydrated malnourished children in a Madagascar hospital. Eur J Clin Nutr (1995) 0.77
Interleukin 2 interacts with myeloid growth factors in serum-free long-term bone marrow culture. Br J Haematol (1994) 0.77
Normal human granulopoiesis revisited. I. Blood data. Biomed Pharmacother (1984) 0.76
[Is the dilution of milk necessary in benign acute diarrhea in eutrophic infants?]. Arch Fr Pediatr (1989) 0.76
[Clinical consequences of replacing milk with yogurt in persistent infantile diarrhea]. Ann Pediatr (Paris) (1992) 0.76
In vivo protection of normal mouse hematopoiesis by a beta 2 blocking agent during S-phase chemotherapy. Cancer Res (1984) 0.76
Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol (1996) 0.76
Evaluation of a model to predict recurrence after radical cystectomy in bilharzial bladder cancer patients. Br J Cancer (1989) 0.75
Calprotectin and IBD. Gut (2005) 0.75
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders]. Ann Gastroenterol Hepatol (Paris) (1993) 0.75
[Experimental bases of the in vitro treatment of leukemic bone marrow by a derivative of cyclophosphamide: ASTA Z 7557]. C R Acad Sci III (1985) 0.75
Presence of elevated serum interleukin-2 levels in pregnant women. N Engl J Med (1990) 0.75
Long-term effects of high doses of cytosine arabinoside on pluripotent stem cells (CFU-S). Exp Hematol (1989) 0.75
Conditions of validation and use of the screening method for vaccine efficacy evaluation. Rev Epidemiol Sante Publique (1993) 0.75
[Effect of pentagastrin on intestinal absorption in man]. Biol Gastroenterol (Paris) (1971) 0.75
[Validity of the D-xylose test for the detection of the proximal small intestine lesions. Statistical study of the discriminant parameters and of their cut-off values (author's transl)]. Biol Gastroenterol (Paris) (1976) 0.75
Revisiting statistical methods to assess the effect of hematopoietic inhibitors using colony-forming assays. Ann N Y Acad Sci (1991) 0.75
[Does parenteral nutrition-induced fatty liver depend on the amount of glucose supplied? (author's transl)]. Gastroenterol Clin Biol (1977) 0.75
Is P50 the most representative P(SO2) to evaluate HbO2 affinity? Scand J Clin Lab Invest Suppl (1990) 0.75
Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557). Bone Marrow Transplant (1987) 0.75
Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation. Bone Marrow Transplant (1991) 0.75
Sex-dependent effects of non-H-2 loci on lethal GVH reaction induced across an H-2 barrier. Immunogenetics (1986) 0.75
[Mixed lympho-epidermal cell cultures: value in bone marrow grafts]. Presse Med (1989) 0.75
Size and weight study of human kidney growth velocity during the last three months of pregnancy. Eur Urol (1980) 0.75
[Value of multidimensional analysis in clinical research]. Rev Prat (1983) 0.75
Growth fraction of myelocytes in normal human granulopoiesis. Cell Tissue Kinet (1986) 0.75
[Glycosylated hemoglobin and blood viscosity]. Journ Annu Diabetol Hotel Dieu (1979) 0.75
Preferential differentiation of murine CFU-S toward granulopoiesis and megakaryocytopoiesis after in vitro incubation of bone marrow with ASTA-Z 7557. Exp Hematol (1987) 0.75
A French cluster of Creutzfeldt-Jakob disease: a molecular analysis. Eur J Neurol (2002) 0.75
Towards an objective prognostic index of acute graft-versus-host disease. Anal Cell Pathol (1993) 0.75
Decrease in the ability of CFU-s in shielded marrow to be recruited into cell cycle after multiple irradiations: experimental results and computer simulations. Cell Tissue Kinet (1984) 0.75
In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation. Exp Hematol (1993) 0.75
A case-control study of aplastic anaemia: occupational exposures. The French Cooperative Group for Epidemiological Study of Aplastic Anaemia. Int J Epidemiol (1995) 0.75
Proceedings: The influence of ethacrynic acid and aspirin on water and electrolyte secretion induced by prostaglandin E1 in the human jejunum. Gut (1974) 0.75
Relationship between vitamin A and malignancy in cancer patients. Int J Vitam Nutr Res (1985) 0.75
[Value of the D-xylose test in disorders of the intestinal mucosa and use of French in medical publications]. Nouv Presse Med (1976) 0.75
Statistical analysis of splenic colony histology: an attempt to confirm that external factors could affect the channelling of CFUS differentiation. Exp Hematol (1983) 0.75
Risk factors for AIDS among homosexual men in a moderate incidence area. Int J Epidemiol (1987) 0.75
The mixed epidermal cell lymphocyte-reaction is the most predictive factor of acute graft-versus-host disease in bone marrow graft recipients. Br J Haematol (1988) 0.75
Power calculation for the likelihood ratio-test when comparing two dependent intraclass correlation coefficients. Comput Methods Programs Biomed (2005) 0.75
Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557). Exp Hematol (1989) 0.75
[Leukocyte differential of the Coulter VCS. Evaluation and modalities of use in comparison with the Coulter STKR and manual count]. Ann Biol Clin (Paris) (1990) 0.75
Risk factors for A.I.D.S. among homosexual men in France. Eur J Epidemiol (1988) 0.75
Kappa as an index of reproducibility: distribution under the null-hypothesis. Rev Epidemiol Sante Publique (1987) 0.75
A classification after radical cystectomy of patients with bladder cancer associated with schistosomiasis. Eur J Cancer (1994) 0.75
[Method of computer analysis of labelled mitosis curves]. Biomedicine (1973) 0.75